SCHOTT Pharma
Richard Mainone is a seasoned professional with extensive experience in the manufacturing and IT sectors, currently serving as a Senior Engineer and Global System Owner for MES at SCHOTT Pharma since September 2022. Previously, Richard held the position of MES Expert in the Service & Solution Pharma unit at SCHOTT from July 2020 to August 2022. Richard's career includes significant roles at Flex as an IT MES Developer and IT MES Engineer, contributing to customer implementation and support in various sectors, including Lenovo Computing and Automotive. Early career experience includes IT Associate at The Linde Group and software engineering positions at HARMAN International, focusing on Automotive Electronics. Richard holds a Bachelor's Degree in IT Engineering and a Master's Degree in Computer Science Engineering, both from the University of Pannonia.
This person is not in any teams
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social